Hims & Hers Health reported a net loss of 37 cents per share for the second quarter, a significant decline from a net income of 17 cents per share in the same period last year. This loss was primarily driven by increased expenses, which have raised concerns among investors.
However, the company did provide a positive note by raising its full-year revenue outlook, indicating potential growth despite the current financial setback. The market's reaction, reflected in the nearly 6% drop in share price, suggests that investors are weighing the implications of the loss against the company's optimistic revenue forecast